These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16002173)

  • 61. Evaluating gelatin based nanoparticles as a carrier system for double stranded oligonucleotides.
    Zillies J; Coester C
    J Pharm Pharm Sci; 2005 Feb; 7(4):17-21. PubMed ID: 15850544
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.
    Xie YL; Lu W; Jiang XG
    Behav Brain Res; 2006 Oct; 173(1):76-84. PubMed ID: 16828890
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nanoparticles--an efficient carrier for drug delivery into the hair follicles.
    Lademann J; Richter H; Teichmann A; Otberg N; Blume-Peytavi U; Luengo J; Weiss B; Schaefer UF; Lehr CM; Wepf R; Sterry W
    Eur J Pharm Biopharm; 2007 May; 66(2):159-64. PubMed ID: 17169540
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
    Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
    Kratz F
    J Control Release; 2008 Dec; 132(3):171-83. PubMed ID: 18582981
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
    Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
    Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Defoliation and plasmid delivery with layer-by-layer coated colloids.
    Reibetanz U; Claus C; Typlt E; Hofmann J; Donath E
    Macromol Biosci; 2006 Feb; 6(2):153-60. PubMed ID: 16456874
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.
    Enríquez de Salamanca A; Diebold Y; Calonge M; García-Vazquez C; Callejo S; Vila A; Alonso MJ
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1416-25. PubMed ID: 16565375
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture.
    Pongpeerapat A; Wanawongthai C; Tozuka Y; Moribe K; Yamamoto K
    Int J Pharm; 2008 Mar; 352(1-2):309-16. PubMed ID: 18162340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functionalization of calcium carbonate microparticles as a combined sensor and transport system for active agents in cells.
    Reibetanz U; Chen MH; Mutukumaraswamy S; Liaw ZY; Oh BH; Donath E; Neu B
    J Biomater Sci Polym Ed; 2011; 22(14):1845-59. PubMed ID: 20961492
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of PEGylated and non-PEGylated proticles: An in vitro and in vivo study.
    Fresacher K; Helbok A; Reiser M; Blass S; Rangger C; Mair C; von Guggenberg E; Decristoforo C; Andreae F; Zimmer A
    Eur J Pharm Sci; 2019 Nov; 139():105063. PubMed ID: 31487537
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stable cellulose nanospheres for cellular uptake.
    Liebert T; Kostag M; Wotschadlo J; Heinze T
    Macromol Biosci; 2011 Oct; 11(10):1387-92. PubMed ID: 21830298
    [TBL] [Abstract][Full Text] [Related]  

  • 74. DNA condensation by protamine and arginine-rich peptides: analysis of toroid stability using single DNA molecules.
    Balhorn R; Brewer L; Corzett M
    Mol Reprod Dev; 2000 Jun; 56(2 Suppl):230-4. PubMed ID: 10824973
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Re-electrospraying splash-landed proteins and nanoparticles.
    Benner WH; Lewis GS; Hering SV; Selgelke B; Corzett M; Evans JE; Lightstone FC
    Anal Chem; 2012 Mar; 84(5):2498-504. PubMed ID: 22283555
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of protamine uptake by opossum kidney epithelial cells.
    Nagai J; Komeda T; Katagiri Y; Yumoto R; Takano M
    Biol Pharm Bull; 2013; 36(12):1942-9. PubMed ID: 24292053
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium.
    Pardridge WM; Buciak JL; Kang YS; Boado RJ
    J Clin Invest; 1993 Nov; 92(5):2224-9. PubMed ID: 8227337
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oligonucleoside phosphorothioates.
    Zon G
    Methods Mol Biol; 1993; 20():165-89. PubMed ID: 8242135
    [No Abstract]   [Full Text] [Related]  

  • 79. Peptide fragments of human serum albumin as novel renal targeting carriers.
    Yuan ZX; He XK; Wu XJ; Gao Y; Fan M; Song LQ; Xu CQ
    Int J Pharm; 2014 Jan; 460(1-2):196-204. PubMed ID: 24184033
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Maghemite nanoparticles and their protamine derivatives: cellular internalization and effects on cell-cycle progress.
    Xia JG; Zhang S; Zhang Y; Ma M; Gu N
    J Nanosci Nanotechnol; 2009 Feb; 9(2):1025-8. PubMed ID: 19441446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.